Proper Pressure and Duration of Sustained Lung Inflation in Preterm Infants
Launched by MANSOURA UNIVERSITY CHILDREN HOSPITAL · Jul 22, 2016
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
This study will be a randomized prospective pilot study in Mansoura University Hospital then the cases were followed at Neonatal Intensive Care Unit in Mansoura University Children Hospital, Mansoura, Egypt.
Preterm infants born equal to or less than 32 weeks gestation with respiratory distress syndrome will be included in the study.
We aim to study the proper pressure and duration of sustained lung inflation in the delivery room.
Preterm infants will be divided into 5 groups:
1. Group 1 (Control group). In this group preterm infants will not be treated with sustained lung inflation and...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm infants with gestational age ≤ 32 weeks' gestation, presented with respiratory distress syndrome at birth
- Exclusion Criteria:
- • 1. - Preterm infants with no manifestations of respiratory distress syndrome at birth.
- • 2. - Presence of major congenital malformation (dysmorphic features or anomalies incompatible with life) .
About Mansoura University Children Hospital
Mansoura University Children Hospital is a leading pediatric healthcare institution dedicated to advancing children's health through innovative clinical research and comprehensive care. As a prominent sponsor of clinical trials, the hospital focuses on developing and evaluating new therapies, interventions, and diagnostic tools aimed at improving health outcomes for pediatric patients. With a multidisciplinary team of expert clinicians and researchers, Mansoura University Children Hospital is committed to fostering a collaborative research environment that emphasizes ethical standards, scientific rigor, and patient safety, ultimately striving to enhance the quality of care provided to children in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansoura, El Dakahlya, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials